文献速递慢性肾脏病遗传性与小管间质肾病

钙黏蛋白-11通过改变肾脏成纤维细胞力学生物学介导肾损伤

Cadherin-11 mediates kidney injury through altered renal fibroblast mechanobiology.
PubMed 文献 · Kidney Int · 2026-07-22

该研究在单侧输尿管梗阻、马兜铃酸肾病及单肾切除联合血管紧张素II输注三种小鼠模型中,测试了Cdh11基因敲除与CDH11阻断抗体SY0012对肾损伤的作用。结果显示靶向CDH11可减轻纤维化与炎症、改善肾功能并保护心脏重构,机制与降低肾脏成纤维细胞收缩性及组织僵硬有关。

要点

  • 靶向CDH11可减轻多种肾损伤模型的纤维化和炎症。
  • Cdh11缺失改善肾功能并减少循环损伤标志物。
  • CDH11阻断抗体SY0012重现了基因敲除的主要保护效应。

核心结论

  • 靶向CDH11可减轻多种模型中的肾损伤,改善肾功能、减少纤维化和炎症,并保护下游心脏重构。
  • CDH11是肾脏成纤维细胞力学生物学的关键分子,限制组织僵硬从而抑制损伤传播。

研究设计与样本

  • 研究使用三种小鼠肾损伤模型:单侧输尿管梗阻、马兜铃酸肾病、单肾切除联合血管紧张素II输注。
  • 方法包括Cdh11基因敲除与CDH11阻断抗体SY0012干预,分离肾脏成纤维细胞检测CDH11介导的环境响应。
  • 使用细胞因子阵列定量分泌变化,原子力显微镜测量组织硬度。

主要发现

  • 损伤后CDH11表达增加并定位于肾间质。
  • 单侧输尿管梗阻模型中,Cdh11-/-小鼠纤维化减少,循环炎症、纤维化及肾损伤标志物水平降低。
  • 马兜铃酸肾病模型中,Cdh11-/-小鼠生存率改善且血浆BUN功能改善。
  • 单肾切除联合血管紧张素II输注模型中,Cdh11-/-小鼠功能改善且心肾损伤标志物减弱。
  • Cdh11-/-肾脏成纤维细胞收缩性和对牵张的敏感性降低,单侧输尿管梗阻后纤维化微环境组织僵硬受限。

临床怎么用

  • CDH11可作为限制慢性肾脏病进展的潜在新靶点。
  • SY0012抗体在三种损伤模型中重现了基因敲除的主要保护效应,支持其转化潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Cadherin-11 (CDH11) is a mechanosensitive protein capable of creating cell-cell and cell-substrate junctions governing responses to environmental stimuli. It is known to perpetuate fibroblast activation and an inflammatory environment, so we hypothesized that CDH11 is a viable target to suppress kidney injury. METHODS: Three models were used to test the efficacy of Cdh11 ablation and the CDH11 blocking antibody SYN0012 on kidney injury outcomes: unilateral ureteral obstruction, aristolochic acid nephropathy, and uninephrectomy with angiotensin II infusion. Kidney fibroblasts were isolated to test CDH11-mediated response to environmental cues. Cytokine arrays were used to quantify secretory changes, and atomic force microscopy was used to measure tissue stiffness. RESULTS: CDH11 increased after injury and was localized to the interstitium. Cdh11-/- mice had reduced fibrosis and decreased circulating levels of inflammatory, fibrotic, and kidney injury markers after unilateral ureteric obstruction. Cdh11-/- mice had improved survival and kidney function (plasma BUN) in the aristolochic acid nephropathy model, while in the uninephrectomy model with angiotensin II infusion, Cdh11-/- mice had improved function and muted cardiorenal injury markers. Contractility and sensitivity to strain in Cdh11-/- kidney fibroblasts were decreased, and these effects are further supported by limited tissue stiffening of the fibrogenic niche after unilateral ureteric obstruction. SYN0012 recapitulated the major findings in all three injury models. CONCLUSIONS: Targeting CDH11 attenuates kidney injury in multiple models to improve kidney function, decrease fibrosis and inflammation, and protect from downstream cardiac remodeling. This establishes CDH11 as a major player in renal fibroblast mechanobiology, limiting tissue stiffening and therefore propagation of injury. Hence, CDH11 targeting may be a novel strategy to limit expansion of chronic kidney disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Huffstater TM, Snider JC, Noll NA, et al. Cadherin-11 mediates kidney injury through altered renal fibroblast mechanobiology. Kidney Int. 2026. PMID: 42486192. doi:10.1016/j.kint.2026.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。